Psoriasin: Key molecule of the cutaneous barrier?;Psoriasin: Schlüsselsubstanz bei der barriereschädigung?

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 11, 2011, Pages 897-903

  Gläser, Regine ^a   Köten, Bente ^a   Wittersheim, Maike ^a   Harder, Jürgen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Antimicrobial peptides; Barrier; Differentiation; Keratinocyte; Psoriasin; Psoriasis; S 100 proteins

Indexed keywords

CYTOKERATIN 17; CYTOKERATIN 6; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN S 100; PSORIASIN;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BREAST CARCINOMA; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 1Q; DRUG DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; INFLAMMATION; KERATINOCYTE; LICHEN STRIATUS; MASS SPECTROMETRY; MEDICAL RESEARCH; PROTEIN EXPRESSION; PSORIASIS; REGULATORY MECHANISM; REVIEW; TUMOR GROWTH;

ANTI-INFECTIVE AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOMODULATION; KERATINOCYTES; NEOPLASMS; PSORIASIS; S100 PROTEINS; SKIN; SKIN ABSORPTION; SKIN DISEASES; SKIN NEOPLASMS; WOUNDS AND INJURIES;

EID: 84055212347     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07683.x     Document Type: Review

References (56)

1. Celis JE, Cruger D, Kiil J, Dejgaard K, Lauridsen JB, Ratz G P, Basse B, Celis A, Rasmussen HH, Bauw G, Vandekerckhoue J. A two-dimensional gel protein database of noncultured total normal human epidermal keratinocytes: identification of proteins strongly up-regulated in psoriatic epidermis. Electrophoresis 1990;11:242-54. (Pubitemid 20207461)
2. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, Lauridsen JB, Ratz G P, Celis A, Vandekerckhove J, Celis JE. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991;97:701-12.
3. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-44.
4. Fritz G, Botelho HM, Morozova-Roche LA, Gomes CM. Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. Febs J 2010;277:4578-90.
5. Hardas BD, Zhao X, Zhang J, Longqing X, Stoll S, Elder J T. Assignment of psoriasin to human chromosomal band 1q21: coordinate overexpression of clustered genes in psoriasis. J Invest Dermatol 1996;106:753-8. (Pubitemid 26119735)
6. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995;25:638-43.
7. Kulski JK, Lim C P, Dunn DS, Bellgard M. Genomic and phylogenetic analysis of the S100A7 (psoriasin) gene duplications within the Region of the S100 gene gluster on human chromosome 1q21. J Mol Evol 2003;56:397-406. (Pubitemid 36390771)
8. Hoffmann HJ, Olsen E, Etzerodt M, Madsen P, Thogersen HC, Kruse T, Celis JE. Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin. J Invest Dermatol 1994;103:370-5. (Pubitemid 24329759)
9. Olsen E, Rasmussen HH, Celis JE. Identification of proteins that are abnormally regulated in differentiated cultured human keratinocytes. Electrophoresis 1995;16:2241-8. (Pubitemid 26024338)
10. Algermissen B, Sitzmann J, Le Motte P, Czarnetzki B. Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch Dermatol Res 1996;288:426-30. (Pubitemid 26282734)
11. Schaefer BM, Wallich R, Schmolke K, Fink W, Bechtel M, Reinartz J, Kramer MD. Immunohistochemical and molecular characterization of cultured keratinocytes after dispase-mediated detachment from the growth substratum. Exp Dermatol 2000;9:58-64. (Pubitemid 30093038)
12. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Wolf H, Orntoft T F. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996;155:2105-12. (Pubitemid 26146716)
13. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 1997;57:4111-7. (Pubitemid 27427705)
14. Ostergaard M, Wolf H, Orntoft TF, Celis JE. Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas. Electrophoresis 1999;20:349-54. (Pubitemid 29125022)
15. Moog-Lutz C, Bouillet P, Regnier CH, Tomasetto C, Mattei MG, Chenard M P, Anglard P, Rio MC, Basset P. Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int J Cancer 1995;63:297-303.
16. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC, Watson PH. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 1996;56:4606-9. (Pubitemid 26338057)
17. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003;63:1954-61. (Pubitemid 36460863)
18. Zhou G, Xie TX, Zhao M, Jasser SA, Younes MN, Sano D, Lin J, Kupferman ME, Santillan AA, Patel V, Gutkind JS, Ei-Naggar AK, Emberley ED, Watson PH, Matsuzawa SI, Reed JC, Myers JN. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signalling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene 2008;27:3527-38. (Pubitemid 351793795)
19. Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P, Gunsior M, Vonderhaar BK, Olson M, Watson PH, Yuspa SH. Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett 2009;277:101-7.
20. Bürgisser DM, Siegenthaler G, Kuster T, Hellman U, Hunziker P, Birchler N, Heizmann CW. Amino acid sequence analysis of human S100A7 (psoriasin) by tandem mass spectrometry. Biochem Biophys Res Commun 1995;217:257-63. (Pubitemid 26004788)
21. Vorum H, Madsen P, Rasmussen HH, Etzerodt M, Svendsen I, Celis JE, Honore B. Expression and divalent cation binding properties of the novel chemotactic inflammatory protein psoriasin. Electrophoresis 1996;17:1787-96. (Pubitemid 26402938)
22. Brodersen DE, Etzerodt M, Madsen P, Celis JE, Thogersen HC, Nyborg J, Kjeldgaard M. EF-hands at atomic resolution: the structure of human psoriasin (S100A7) solved by MAD phasing. Structure 1998;6:477-89. (Pubitemid 28205519)
23. 2+-free states. Biochemistry 1999;38:1695-704.
24. Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honore B, Celis JE, Thestrup-Pedersen K. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996;107:5-10.
25. Hagens G, Roulin K, Hotz R, Saurat JH, Hellman U, Siegenthaler G. Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales. Mol Cell Biochem 1999;192:123-8. (Pubitemid 29171461)
26. Hagens G, Masouye I, Augsburger E, Hotz R, Saurat JH, Siegenthaler G. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes. Biochem J 1999;339:419-27. (Pubitemid 29209974)
27. Ruse M, Lambert A, Robinson N, Ryan D, Shon KJ, Eckert RL. S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 2001;40:3167-73. (Pubitemid 32205361)
28. Emberley ED, Gietz RD, Campbell JD, HayGlass KT, Murphy LC, Watson PH. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer. BMC Cancer 2002;2:28.
29. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003;63:1954-61. (Pubitemid 36460863)
30. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, Chavakis T, Oppenheim JJ, Yuspa SH. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 2008;181:1499-506.
31. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005;6:57-64.
32. Lee KC, Eckert RL. S100A7 (Psoriasin) - mechanism of antibacterial action in wounds. J Invest Dermatol 2007;127:945-57. (Pubitemid 46434664)
33. Michalek M, Gelhaus C, Hecht O, Podschun R, Schröder JM, Leippe M, Grotzinger J. The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes. Dev Comp Immunol 2009;33:740-6.
34. Liang SC, Tan XY, Luxenberg D P, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. Interleukin (IL) - 22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271-9. (Pubitemid 44498362)
35. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006;36:1309-23.
36. Abtin A, Eckhart L, Mildner M, Gruber F, Schröder JM, Tschachler E. Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. Faseb J 2008;22:2168-76. (Pubitemid 351948636)
37. Di Nuzzo S, Sylva-Steenland RM, Koomen CW, de Rie MA, Das PK, Bos JD, Teunissen MB. Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem Photobiol 2000;72:374-82.
38. Gläser R, Navid F, Schuller W, Jantschitsch C, Harder J, Schröder JM, Schwarz A, Schwarz T. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 2009;123:1117-23.
39. Alowami S, Qing G, Emberley E, Snell L, Watson PH. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol 2003;3:1.
40. Reithmayer K, Meyer KC, Kleditzsch P, Tiede S, Uppalapati SK, Gläser R, Harder J, Schröder JM, Paus R. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol 2009;161:78-89.
41. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, Agerberth B. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003;53:211-6. (Pubitemid 36177115)
42. Tollin M, Jagerbrink T, Haraldsson A, Agerberth B, Jornvall H. Proteome analysis of vernix caseosa. Pediatr Res 2006;60:430-4. (Pubitemid 44427595)
43. Porre S, Heinonen S, Mantyjarvi R, Rytkonen-Nissinen M, Perola O, Rautiainen J, Virtanen T. Psoriasin, a calcium-binding protein with chemotactic properties is present in the third trimester amniotic fluid. Mol Hum Reprod 2005;11:87-92. (Pubitemid 40331288)
44. Meyer JE, Harder J, Sipos B, Maune S, Kloppel G, Bartels J, Schröder JM, Gläser R. Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongue. Mucosal Immunol 2008;1:239-43. (Pubitemid 351541309)
45. Garreis F, Gottschalt M, Paulsen F P. Antimicrobial peptides as a major part of the innate immune defense at the ocular surface. Dev Ophthalmol 2010;45:16-22.
46. Bryborn M, Adner M, Cardell LO. Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry. Respir Res 2005;6:118.
47. Mildner M, Stichenwirth M, Abtin A, Eckhart L, Sam C, Gläser R, Schröder JM, Gmeiner R, Mlitz V, Pammer J, Geusau A, Tschachler E. Psoriasin (S100A7) is a major Escherichia colicidal factor of the female genital tract. Mucosal Immunol 2010;3:602-9.
48. Kim KH, Cho JG, Song JJ, Woo JS, Lee HM, Jung HH, Hwang SJ, Chae S. Psoriasin (S100A7), an antimicrobial peptide, is increased in human middle ear cholesteatoma. Acta Otolaryngol 2009:1-5.
49. Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008;147:17-24.
50. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Folster-Holst R, Proksch E, Schröder JM, Schwarz T, Gläser R. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010;130:1355-64.
51. Harder J, Schröder JM. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005;77:476-86. (Pubitemid 40489523)
52. Gläser R, Meyer-Hoffert U, Harder J, Cordes J, Wittersheim M, Kobliakova J, Folster-Holst R, Proksch E, Schröder JM, Schwarz T. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009;129:641-9.
53. Dressel S, Harder J, Cordes J, Wittersheim M, Meyer-Hoffert U, Sunderkotter C, Gläser R. Differential expression of antimicrobial peptides in margins of chronic wounds. Exp Dermatol 2010;19:628-32.
54. Gambichler T, Skrygan M, Tigges C, Kobus S, Gläser R, Kreuter A. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus. Br J Dermatol 2009;161:1136-42.
55. Schlapbach C, Yawalkar N, Hunger RE. Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. J Am Acad Dermatol 2009;61:58-65.
56. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Gläser R. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007;133:253-61.